Preliminary Study on the Leukemia Targeting by a CD19 Antibody Conjugated with Saline Extracts from Mylabris Phalerata Pallas.
Yongmin Tang,Haizhong Zhang,Sisi Li,Baiqin Qian,Hongqiang Shen,Chunfang Luo,Yi Zhang
DOI: https://doi.org/10.1182/blood.v110.11.4189.4189
IF: 20.3
2007-01-01
Blood
Abstract:Introduction and Objectives As a potent ligand for an immunotoxin, many moieties have been tried. However, majority of those moieties were large molecules or proteins which may produce human anti-toxin antibodies or were radioisotopes which may generate the concerns of the radioactive contaminations. Thus a small, non-protein toxin is desired to avoid the above disadvantages. Our hypothesis was that there could be a water soluble toxin in the saline extract of a Chinese medicine Mylabris phalerata Pallas (SEM) and easy to be conjugated with antibody proteins to generate immunotoxin. In this study, the toxin (s) in SEM was used to conjugate with our anti-CD19 monoclonal antibody ZCH-4-2E8 (2E8) protein and targeting efficacy on leukemia cells was tested to elucidate its leukemia-specific targeting efficacy and its mechanisms.
What problem does this paper attempt to address?